Stock listing
Medrx Co., Ltd.
Selected listing: 4586 · TSE · JPY · JP
Medrx Co., Ltd. (Tokyo:4586), Health Technology. Latest release May 23, 2025: MedRx : Results of MRX-7MLL Phase I a Clinical Trial.
- Ticker
- Tokyo:4586
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Medrx Co., Ltd.
Medrx Co., Ltd. is a public company listed on the Japanese stock market under the ticker 4586. Medrx focuses on developing innovative healthcare solutions.
Latest news from Medrx Co., Ltd.
MedRx : Results of MRX-7MLL Phase I a Clinical Trial
May 23, 2025
MedRx : Summary of Business Results for the First Quarter Ended March 31, 2025 (Consolidated)
May 20, 2025
MedRx : FDA Acceptance of New Drug Application for MRX-5LBT (“Lydolyte”)
April 2, 2025
MedRx : Summary of Business Results for the Third Quarter Ended September 30, 2024 (Consolidated)
November 8, 2024
MedRx : Start of MRX-7MLL Phase I a Clinical Trial
October 28, 2024